Cytokinetics CYTK Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's shares (basic)?
- Cytokinetics (CYTK) reported shares (basic) of 123.3M in Q1 2026.
- How has Cytokinetics's shares (basic) changed year-over-year?
- Cytokinetics's shares (basic) increased by 4.0% year-over-year, from 118.5M to 123.3M.
- What is the long-term trend for Cytokinetics's shares (basic)?
- Over 3 years (2022 to 2025), Cytokinetics's shares (basic) has grown at a 10.5% compound annual growth rate (CAGR), from 354.3M to 478M.
- What does shares (basic) mean?
- The average number of shares held by investors throughout the reporting period.
- How do you interpret shares (basic)?
- An increase suggests equity issuance or share-based compensation, which can lead to dilution for existing shareholders.
- How does shares (basic) compare across companies?
- Standard metric for all public companies to track equity base changes.